By Dr. Gail Tomblin Murphy April’s federal budget announcement of $1.8 billion over five years to support Canadian research prompted...
Profile Category: Blog
More than just medicines: Canada’s innovative pharmaceutical industry is contributing to the country’s overall health
The pride Canadians feel toward the country’s health-care system has declined in recent decades. Beyond the well-documented doctor shortages and...
University of Alberta spin-off company Nanostics provides new prostate cancer test to men across Canada
Nanostics, a private Canadian company developing diagnostic tests with its ClarityDX® platform technology, has expanded access to its ClarityDX Prostate...
A New Technological Solution for Children with Sound Sensitivity
British Columbia-based researchers are developing a device that will help kids with decreased sound tolerance to participate fully — and...
Research and patient engagement key to advancing care for Ehlers-Danlos Syndromes
The ILC Charitable Foundation (The ILC) organizes and funds programs to support its strategy to raise awareness about Ehlers-Danlos Syndromes/Hypermobility...
Diabetes researchers in Canada need our support
By Russell Williams, Senior Vice President of Mission, Diabetes Canada Since the discovery of insulin over 100 years ago, diabetes...
The case for physical activity as a treatment option for Canadians living with diabetes
The Canadian Society for Exercise Physiology (CSEP) is the national not-for-profit organization that certifies professional Clinical Exercise Physiologists (CSEP-CEPs) in...
Interview Availability: Patient Perspectives on National Pharmacare Issues
OTTAWA, February 28, 2024 – Patient advocates affiliated with the Best Medicines Coalition (BMC) are available to offer comment regarding national pharmacare...
State of Celiac Disease in Canada – Underdiagnosed, Unaffordable and Unsafe Food: Survey
20 years after first survey, little has changed for hundreds of thousands of Canadians living with celiac disease TORONTO, February...
ALS Canada and Brain Canada invest in future leader of ALS research with 2023 Career Transition Award
Quebec researcher receives $250,000 over three years to investigate gene-based research to treat ALS TORONTO, February 27, 2024 – The ALS Society of...
- 1
- 2